…
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -26.99M | -16.14M | -3.87M | - |
| Net income | -26.47M | -15.98M | -4.41M | - |
| Selling general administrative | 12.32M | 8.06M | 1.50M | - |
| Selling and marketing expenses | 6.94M | 4.96M | 0.03M | - |
| Gross profit | 7.21M | 3.94M | 0.00M | - |
| Reconciled depreciation | 4.14M | 2.06M | 0.15M | - |
| Ebit | -26.68M | -15.86M | -3.37M | -1.73M |
| Ebitda | -22.31M | -13.63M | -3.19M | - |
| Depreciation and amortization | 4.37M | 2.23M | 0.18M | - |
| Operating income | -26.68M | -15.86M | -3.37M | - |
| Other operating expenses | 51.03M | 30.09M | 3.37M | - |
| Interest expense | 0.27M | 0.43M | 0.52M | 0.00M |
| Tax provision | -0.52M | -0.15M | 0.00M | - |
| Net interest income | -0.27M | -0.43M | -0.52M | - |
| Income tax expense | -0.52M | -0.15M | 0.55M | - |
| Total revenue | 24.34M | 14.23M | 0.00M | - |
| Total operating expenses | 33.89M | 19.80M | 3.37M | - |
| Cost of revenue | 17.14M | 10.29M | 0.00M | - |
| Total other income expense net | -0.31M | -0.27M | -0.50M | - |
| Net income from continuing ops | -26.47M | -15.98M | -3.87M | - |
| Net income applicable to common shares | -26.47M | -15.98M | -3.87M | -1.82M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 31.68M | 49.95M | 44.20M | 6.53M | 4.24M |
| Intangible assets | 7.30M | 10.91M | 11.81M | 3.82M | 3.25M |
| Other current assets | 0.89M | 1.60M | 0.74M | 0.26M | 0.02M |
| Total liab | 45.12M | 43.82M | 14.49M | 10.03M | 5.11M |
| Total stockholder equity | -13.44M | 6.13M | 29.71M | -3.50M | -0.87M |
| Other current liab | 15.02M | 14.30M | 8.07M | 0.51M | 0.07M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -76.75M | -47.99M | -21.52M | -5.54M | -1.67M |
| Other liab | - | 21.68M | 2.05M | - | - |
| Good will | 3.02M | 5.84M | 2.38M | - | - |
| Other assets | 0.00M | 1.31M | 0.08M | - | - |
| Cash | 13.49M | 13.76M | 19.18M | 1.75M | 0.19M |
| Total current liabilities | 20.84M | 17.36M | 11.14M | 2.65M | 0.20M |
| Current deferred revenue | 0.66M | 0.29M | 1.17M | - | - |
| Net debt | -9.30M | -7.68M | -17.10M | 7.59M | 4.81M |
| Short term debt | 0.51M | 1.31M | 0.78M | 1.96M | 0.09M |
| Short long term debt | - | - | - | 1.87M | - |
| Short long term debt total | 4.20M | 6.08M | 2.09M | 9.34M | 5.00M |
| Other stockholder equity | 63.31M | 54.13M | 51.23M | 2.04M | 0.80M |
| Property plant equipment | - | 5.35M | 2.93M | 0.53M | 0.70M |
| Total current assets | 17.08M | 26.54M | 26.99M | 2.18M | 0.29M |
| Net tangible assets | - | -10.61M | 15.51M | -7.32M | -4.12M |
| Net receivables | 2.70M | 1.82M | 0.32M | 0.10M | 0.03M |
| Long term debt | - | - | - | 7.10M | 4.53M |
| Inventory | - | 9.35M | 6.75M | 0.06M | 0.06M |
| Accounts payable | 4.65M | 1.46M | 1.13M | 0.17M | 0.04M |
| Non currrent assets other | 1.29M | 1.31M | 0.08M | - | - |
| Non current assets total | 14.59M | 23.41M | 17.21M | 4.35M | 3.95M |
| Capital lease obligations | 4.20M | 6.08M | 2.09M | 0.38M | 0.47M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 32.42M | 9.64M | -0.55M | - |
| Change to liabilities | 0.18M | 0.03M | 0.13M | 0.05M |
| Total cashflows from investing activities | 32.42M | 9.64M | -0.55M | -0.41M |
| Net borrowings | - | -0.23M | 4.08M | 1.64M |
| Total cash from financing activities | 0.00M | 25.27M | 4.08M | 1.64M |
| Change to operating activities | -15.65M | 1.69M | 0.04M | 0.03M |
| Net income | -26.47M | -15.98M | -3.87M | -1.82M |
| Change in cash | -2.82M | 24.12M | 1.57M | 0.27M |
| Begin period cash flow | 25.93M | 1.82M | 0.25M | - |
| End period cash flow | 23.12M | 25.93M | 1.82M | 0.25M |
| Total cash from operating activities | -35.24M | -10.79M | -1.95M | -0.96M |
| Issuance of capital stock | 0.00M | 25.38M | - | - |
| Depreciation | 4.14M | 2.06M | 0.15M | 0.08M |
| Other cashflows from investing activities | - | - | 0.05M | 0.05M |
| Change to account receivables | -0.60M | -0.13M | -0.13M | -0.13M |
| Other cashflows from financing activities | 0.00M | 3.67M | -0.55M | -0.78M |
| Change to netincome | 3.16M | 1.52M | 1.50M | 0.71M |
| Capital expenditures | 0.97M | 1.74M | 0.60M | 0.34M |
| Change in working capital | -16.06M | 1.58M | 0.17M | - |
| Stock based compensation | 3.10M | 1.23M | 1.03M | - |
| Other non cash items | 0.57M | 0.47M | 0.57M | - |
| Free cash flow | -36.20M | -12.54M | -2.55M | - |
Sector: Healthcare Industry: Healthcare Plans
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MRAI Marpai Inc |
- -% |
2.73 | - | - | 0.62 | 1.49 | 0.70 | -1.18 |
| UNH UnitedHealth Group Incorporated |
4.39 1.11% |
398.54 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
| CVS CVS Health Corp |
1.70 2.03% |
85.55 | 55.65 | 10.80 | 0.25 | 1.32 | 0.42 | 17.09 |
| ELV Elevance Health Inc |
-1.89 0.44% |
423.73 | 18.47 | 14.58 | 0.45 | 2.05 | 0.56 | - |
| CI The Cigna Group |
3.67 1.25% |
297.25 | 11.94 | 8.68 | 0.27 | 1.80 | 0.36 | 7.93 |
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
401 Park Avenue South, New York, NY, United States, 10016
855 389 7330
162
| Name | Title | Year Born |
|---|---|---|
| Mr. Edmundo Gonzalez | Co-Founder, CEO, Sec. & Director | 1973 |
| Mr. Yoram Bibring | Chief Financial Officer | 1958 |
| Mr. Arthur Hoath IV | Chief Revenue Officer | 1970 |
| Mr. Yaron I. Eitan | Co-Founder & Chairman | 1956 |
| Dr. Eli David | Co-Founder, Chairman of the Advisory Board & Chief Science Advisor | 1982 |
| Ms. Ronnie Brown | Chief Operating Officer | 1954 |
| Ms. Pamela Burns | VP of Enterprise Sales | NA |
| Mr. Lutz Finger | Pres of Product & Devel. | 1971 |
| Ms. Alice Roth | Pres of Marpai Labs | 1962 |
| Mr. Damien Francis Lamendola | CEO & Director | 1957 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.